Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GLUL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC35A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RANBP9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM204A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH9A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf109 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUBP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SARAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLTM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IPMK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on